EU's Unified Patent Court revokes Dexcom patent in more than a dozen member states
MLex Summary: A revocation counterclaim by Abbott Laboratories succeeded at the Unified Patent Court, or UPC, when a four-member panel agreed that a Dexcom patent is not valid. Moreover, the UPC...To view the full article, register now.
Already a subscriber? Click here to view full article